Periodization Resistance Training on Quality of Life in Females With Hypothyroidism
Launched by CAIRO UNIVERSITY · Dec 27, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how different types of exercise programs, called nonlinear and linear periodized training, can improve the quality of life for women with hypothyroidism, a condition where the thyroid gland doesn’t produce enough hormones. The study is specifically for women aged 35 to 45 who have controlled hypothyroidism, meaning their thyroid hormone levels are within a specific range. Participants should also have a body mass index (BMI) between 30 and 34.9, which indicates they are in the overweight category.
If you qualify and choose to participate, you can expect to engage in structured exercise routines designed to see which type of training has better benefits. However, there are some important exclusions; for example, individuals with certain heart or lung conditions, recent fractures, or those who have had surgery in the past year cannot join. Also, if you are currently participating in any other exercise program, you won’t be eligible. This trial aims to find effective ways to help women with hypothyroidism feel better and improve their overall well-being through exercise.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Be controlled hypothyroidism (TSH level within 0.5 - 4.5 mU/L)
- • Be ranged from 35 to 45 years
- • Female patients
- • Body Mass Index 30-34.9 kg/m2 .
- • triglyceride-glucose (TyG) index \> 4.5
- Exclusion Criteria:
- • history of pulmonary disease
- • Patients with uncontrolled coronary or cerebrovascular disease
- • Those who underwent musculoskeletal surgery within the previous year
- • Recent history of lower and upper limb fracture , hip and shoulder dislocation.
- • Cognitive impaired patients
- • Patients with history of epilepsy
- • Patients who participating in any other exercise program
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Suez, , Egypt
Patients applied
Trial Officials
Nesreen Gharib Mohamed Elnahas, PhD
Study Chair
Professor, Cairo university
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported